🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06864663
Starting soon Not applicable

A Comparative Study of Combined Adductor Canal and Interspace Between Popliteal Artery and Knee Capsule Versus Combined Adductor Canal and Genicular Nerve in Total Knee Arthroplasty

NCT06864663 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-03-15
Last updated
2025-03-07

Condition(s) studied

Nerve BlockRegional Anaesthesia

Investigational drug(s) / intervention(s)

nerve block with bupivacaine 0.25% →Nerve Block with bupivacaine 0.25% →

nerve block with bupivacaine 0.25%: ultrasound guided adductor canal block and interspace between the popliteal artery and the knee capsule using bupivacaine 0.25%

Nerve Block with bupivacaine 0.25%: ultrasound guided combined adductor canal block and genicular nerve block using bupivacaine 0.25%

Study summary

The aim of this study is to investigate the effectiveness of combined adductor canal block (ACB) with interspace between popliteal artery and the knee capsule (IPACK) versus combined ACB with genicular nerve block (GNB) for providing analgesia in knee arthroplasty. The investigators hypothesize that the analgesic efficacy of ACB combined with GNB will be non-inferior to that of ACB combined with IPACK. Additionally, the investigators aim to assess whether the combination of ACB and GNB results in a significantly lower occurrence of sensory or motor block affecting the tibial and common peroneal nerves compared to ACB and IPACK

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: 1. Patients American Society of anesthesiologists' physical status (ASA) I to III. 2. Aged 18 to 70 years. 3. Both sexes. 4. Patients scheduled for total knee arthroplasty. Exclusion Criteria: 1. Patient refusal 2. ASA physical status IV or more. 3. Patients with known allergy to any of the study drugs. 4. Infection at the site of injection. 5. Patients with neuromuscular disease. 6. Presence of any coagulopathy. 7. Patients with history of any psychiatric or cognitive disorder. 8. patient with previous knee surgery. 9. BMI more than 40 kg/m2.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ain Shams University Cairo Egypt

More Ain Shams University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06864663 on ClinicalTrials.gov ↗ ← All trials in Egypt